1218229-30-1 Usage
General Description
2-(methylamino)butanamide is a chemical compound that is also known as SALTDATA: FREE. It belongs to the class of organic compounds known as amides, which are compounds containing a carbonyl group bonded to a nitrogen atom. 2-(methylamino)butanamide(SALTDATA: FREE) has a molecular formula of C5H12N2O and a molecular weight of 116.16 g/mol. It is commonly used in pharmaceutical and research applications. The chemical is also known for its potential biological activity, particularly its role as a potential analgesic and anesthetic. Additionally, it is used in the synthesis of various pharmaceuticals and can act as a cholinergic agonist, affecting the nervous system. Overall, 2-(methylamino)butanamide has diverse applications and is an important compound in the field of chemistry and pharmacology.
Check Digit Verification of cas no
The CAS Registry Mumber 1218229-30-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,8,2,2 and 9 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1218229-30:
(9*1)+(8*2)+(7*1)+(6*8)+(5*2)+(4*2)+(3*9)+(2*3)+(1*0)=131
131 % 10 = 1
So 1218229-30-1 is a valid CAS Registry Number.
1218229-30-1Relevant articles and documents
Identification, characterization, synthesis and strategy for minimization of potential impurities observed in the synthesis of brivaracetam
Liao, Shouzhu,Chen, Hongjun,Wang, Guifei,Wu, Shuming,Yang, Zaiyou,Luo, Weihe,Liu, Zhuanfeng,Gao, Xun,Qin, Junhai,Li, Chuan-hua,Wang, Zhongqing
, (2020/05/25)
A first systematic impurity profile research concerning nine observed and potential process related impurities of antiepileptic drug brivaracetam is reported. Among which three (impurity G/H/I) have not been discovered or reported before, these nine impurities were monitored by HPLC, and their structures were identified on the basis of MS and NMR spectroscopy. In addition to the formation, synthesis, and characterization, strategies for minimizing these impurities to the levels accepted by ICH are also described in this report.
